{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:10:16Z","timestamp":1786133416088,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1681\/asn.2010070750","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T22:14:09Z","timestamp":1303424049000},"page":"914-926","source":"Crossref","is-referenced-by-count":35,"title":["Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal Dialysis"],"prefix":"10.1681","volume":"22","author":[{"given":"Lars P.","family":"Kihm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"M\u00fcller-Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Luise","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonysunil","family":"Adaikalakoteswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thornalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Nawroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20230423","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R2-18-20230423","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R3-18-20230423","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2362.2008.01945.x","article-title":"Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure","volume":"38","author":"Muller-Krebs","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"R4-18-20230423","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1177\/089686080802803s22","article-title":"Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study)","volume":"28","author":"Kim","year":"2008","journal-title":"Perit Dial Int"},{"key":"R5-18-20230423","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/ndt\/gfq087","article-title":"Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: A prospective randomized study","volume":"25","author":"Haag-Weber","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R6-18-20230423","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm834","article-title":"Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy","volume":"9","author":"Hammes","year":"2003","journal-title":"Nat Med"},{"key":"R7-18-20230423","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/dmrr.860","article-title":"Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro","volume":"24","author":"Schmid","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"R9-18-20230423","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.2005020155","article-title":"Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products","volume":"17","author":"Schwenger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R10-18-20230423","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1093\/ndt\/gfn272","article-title":"RAGE expression in the human peritoneal membrane","volume":"23","author":"Kihm","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R11-18-20230423","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1681\/ASN.2007010121","article-title":"Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis","volume":"18","author":"Guo","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R12-18-20230423","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Yanez-Mo","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-18-20230423","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1681\/ASN.V1281734","article-title":"Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane","volume":"12","author":"De Vriese","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R14-18-20230423","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000169582","article-title":"Clinical value of standardized equilibration tests in CAPD patients","volume":"7","author":"Twardowski","year":"1989","journal-title":"Blood Purif"},{"key":"R15-18-20230423","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1681\/ASN.2006030194","article-title":"Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis","volume":"17","author":"Brimble","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R16-18-20230423","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clinbiochem.2006.09.001","article-title":"Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease","volume":"40","author":"Pawlak","year":"2007","journal-title":"Clin Biochem"},{"key":"R17-18-20230423","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1681\/ASN.2006121417","article-title":"Peritoneal changes after exposure to sterile solutions by catheter","volume":"18","author":"Flessner","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R19-18-20230423","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2215\/CJN.03630807","article-title":"Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology","volume":"3","author":"Honda","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-18-20230423","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1681\/ASN.V12102146","article-title":"Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum","volume":"12","author":"Combet","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R22-18-20230423","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","article-title":"Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine","volume":"52","author":"Babaei-Jadidi","year":"2003","journal-title":"Diabetes"},{"key":"R23-18-20230423","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.phrs.2008.09.012","article-title":"Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat","volume":"58","author":"Balakumar","year":"2008","journal-title":"Pharmacol Res"},{"key":"R24-18-20230423","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11010-008-9917-z","article-title":"Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat","volume":"320","author":"Balakumar","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"R25-18-20230423","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1074\/jbc.M600418200","article-title":"Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose","volume":"281","author":"Berrone","year":"2006","journal-title":"J Biol Chem"},{"key":"R26-18-20230423","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1152\/japplphysiol.00988.2005","article-title":"High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus","volume":"100","author":"Ceylan-Isik","year":"2006","journal-title":"J Appl Physiol"},{"key":"R27-18-20230423","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00125-005-0103-5","article-title":"Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B\/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis","volume":"49","author":"Gadau","year":"2006","journal-title":"Diabetologia"},{"key":"R28-18-20230423","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s005920170010","article-title":"Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose","volume":"38","author":"Pomero","year":"2001","journal-title":"Acta Diabetol"},{"key":"R29-18-20230423","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2005.11.016","article-title":"Benfotiamine relieves inflammatory and neuropathic pain in rats","volume":"530","author":"Sanchez-Ramirez","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R30-18-20230423","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000177659","article-title":"Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative","volume":"35","author":"Bitsch","year":"1991","journal-title":"Ann Nutr Metab"},{"key":"R31-18-20230423","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1681\/ASN.V1482109","article-title":"Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane","volume":"14","author":"De Vriese","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R32-18-20230423","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/sj.ki.5001506","article-title":"Oxidative stress during peritoneal dialysis: Implications in functional and structural changes in the membrane","volume":"69","author":"Noh","year":"2006","journal-title":"Kidney Int"},{"key":"R33-18-20230423","first-page":"172","article-title":"Transketolase inhibition as a mechanism in uremic neuropathy","volume":"84","author":"Lange","year":"1971","journal-title":"Trans Assoc Am Physicians"},{"key":"R34-18-20230423","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJM197106242842503","article-title":"Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia","volume":"284","author":"Lonergan","year":"1971","journal-title":"N Engl J Med"},{"key":"R35-18-20230423","first-page":"77","article-title":"Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy","volume":"17","author":"Sterzel","year":"1971","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"R36-18-20230423","first-page":"244","article-title":"Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD)","volume":"20","author":"Blumberg","year":"1983","journal-title":"Clin Nephrol"},{"key":"R37-18-20230423","first-page":"187","article-title":"Deficiencies of vitamins in CAPD patients: The effect of supplementation","volume":"3","author":"Boeschoten","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"R38-18-20230423","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ki.5002574","article-title":"Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function","volume":"73","author":"Fan","year":"2008","journal-title":"Kidney Int"},{"key":"R39-18-20230423","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1523-1755.2003.00705.x","article-title":"Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation?","volume":"63","author":"Zeier","year":"2003","journal-title":"Kidney Int"},{"key":"R40-18-20230423","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1093\/ndt\/gfl402","article-title":"Effect of peritoneal dialysis on renal morphology and function","volume":"21","author":"Breborowicz","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R41-18-20230423","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/01.ASN.0000130154.42061.C6","article-title":"Increased infarct size in uremic rats: Reduced ischemia tolerance?","volume":"15","author":"Dikow","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R42-18-20230423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.1991.175","article-title":"Role of growth hormone in the development of experimental renal scarring","volume":"40","author":"el Nahas","year":"1991","journal-title":"Kidney Int"},{"key":"R43-18-20230423","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.1984.147","article-title":"Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats","volume":"26","author":"Raij","year":"1984","journal-title":"Kidney Int"},{"key":"R44-18-20230423","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/ki.1994.215","article-title":"Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney","volume":"45","author":"Kaneto","year":"1994","journal-title":"Kidney Int"},{"key":"R45-18-20230423","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/ki.1995.183","article-title":"Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction","volume":"47","author":"Ishidoya","year":"1995","journal-title":"Kidney Int"},{"key":"R46-18-20230423","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/oxfordjournals.jbchem.a002889","article-title":"Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro","volume":"129","author":"Thornalley","year":"2001","journal-title":"J Biochem"},{"key":"R47-18-20230423","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1523-1755.2005.00465.x","article-title":"Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membrane","volume":"68","author":"La Milia","year":"2005","journal-title":"Kidney Int"},{"key":"R48-18-20230423","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/clinchem\/35.7.1371","article-title":"Microplate measurement of urinary albumin and creatinine","volume":"35","author":"Magnotti","year":"1989","journal-title":"Clin Chem"},{"key":"R49-18-20230423","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/ki.1990.150","article-title":"Isolation, culture and characterization of human peritoneal mesothelial cells","volume":"37","author":"Stylianou","year":"1990","journal-title":"Kidney Int"},{"key":"R50-18-20230423","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/ndt\/gfh277","article-title":"The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products","volume":"19","author":"Boulanger","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R51-18-20230423","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/089686089501500212","article-title":"In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis","volume":"15","author":"Wieslander","year":"1995","journal-title":"Perit Dial Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201105000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:33:39Z","timestamp":1786131219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201105000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2010070750","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}